This percentage for SDHD mutation carriers is in accordance with a previously published meta‐analysis.2012 None of the 10 SHDB mutation carriers proved to have metastatic disease or developed a PHEO or sPGL, an observation that is most likely due to the limited number of SDHB‐linked patients is in this cohort. The gene discussed is SDHB; the disease is metastatic neoplasm.